Alignment Healthcare financials
$7.91−0.25%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $3.91B | $2.67B | $1.80B | $1.43B | $1.17B |
| Gross profit | $451.6M | $265.1M | $178.3M | $1.43B | $1.17B |
| Gross margin | 11.5% | 9.9% | 9.9% | 100.0% | 100.0% |
| Operating income | -$22.2M | -$133.2M | -$150.5M | -$131.2M | -$177.8M |
| Net income | -$724.0K | -$128.0M | -$148.0M | -$149.5M | -$195.3M |
| Net margin | 0.0% | −4.8% | −8.2% | −10.4% | −16.7% |
| Diluted EPS | $0.00 | $-0.67 | $-0.79 | $-0.83 | $-1.14 |
| EBITDA | $8.2M | -$106.1M | -$128.8M | -$113.8M | -$161.8M |
| Operating cash flow | $139.9M | $34.8M | -$59.2M | -$45.4M | -$78.8M |
| Free cash flow | $113.1M | -$6.6M | -$95.2M | -$69.2M | -$97.1M |
| Diluted shares | 198.0M | 190.8M | 186.2M | 181.2M | 172.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $575.8M | $432.9M | $202.9M | $409.5M | $466.6M |
| Short-term investments | $28.4M | $37.8M | $115.9M | $0.00 | — |
| Total debt | $323.2M | $321.4M | $161.8M | $160.9M | $150.6M |
| Total assets | $1.07B | $782.1M | $591.9M | $633.9M | $630.9M |
| Total liabilities | $886.5M | $681.1M | $433.8M | $394.6M | $324.8M |
| Shareholders' equity | $179.3M | $101.0M | $158.1M | $239.3M | $306.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology